From our Industry Experts

TMCNet:  Research and Markets: Bone Fracture - Pipeline Review, H2 2013 Research Report

[February 07, 2014]

Research and Markets: Bone Fracture - Pipeline Review, H2 2013 Research Report

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/ztg2gl/bone_fracture) has announced the addition of the "Bone Fracture - Pipeline Review, H2 2013" report to their offering.

'Bone Fracture - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Bone Fracture, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bone Fracture.

Scope

- A snapshot of the global therapeutic scenario for Bone Fracture.

- A review of the Bone Fracture products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of montherapy and combined therapeutics.




- Coverage of the Bone Fracture pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Key Topics Covered:

Introduction

Bone Fracture Overview

Therapeutics Development

Pipeline Products for Bone Fracture - Overview

Pipeline Products for Bone Fracture - Comparative Analysis

Bone Fracture - Therapeutics under Development by Companies

Bone Fracture - Therapeutics under Investigation by Universities/Institutes

Bone Fracture - Pipeline Products Glance

Clinical Stage Products

Early Stage Products

Bone Fracture - Products under Development by Companies

Bone Fracture - Products under Investigation by Universities/Institutes

Bone Fracture - Companies Involved in Therapeutics Development

Bone Fracture - Therapeutics Assessment

Drug Profiles

KCB-1B - Drug Profile

Allogeneic Stem Cells - Drug Profile

AZD-2858 - Drug Profile

Bone Regeneration Project - Drug Profile

JVS-200 - Drug Profile

denosumab biosimilar - Drug Profile

Calcitonin Receptor Peptide - Drug Profile

17Beta-HSD2 Inhibitors - Drug Profile

Recombinant BMP-2 Biosimilar - Drug Profile

Nitric Oxide Synthase Antagonist - Drug Profile

Appendix

Companies Mentioned

AstraZeneca PLC

Kaken Pharmaceutical Co., Ltd.

Juventas Therapeutics, Inc.

Laboratorios SALVAT S.A.

ElexoPharm GmbH

Bone Therapeutics SA

bioXPRESS Therapeutics SA

Biogenomics

For more information visit http://www.researchandmarkets.com/research/ztg2gl/bone_fracture

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To Real Time Communications's Homepage ]

Home




  Subscribe here for RTCW eNews   Upcoming Webinars


Featured Videos

Kandy Wrapper: Visual Attendant
Kandy Visual Attendant is ready for resale. The turnkey solution can be custom branded ...

NFV Made Easy
Moving to an NFV gives you An agile and lower cost network. With GENBAND's NFV Solutions ...
Kandy Bus 2016 Connected Experience
Kandy presents A Connected Experience, a three-part fire-starter where we build entire Kandy-enabled ...

View All